TLN1 and cancer: In our previous studies, we explored the cellular consequences of cancer-associated somatic talin-1 mutations [24] and a unique talin-1 variant, P229S, which was found to be associated with diverse symptoms, including thrombocytopenia, lymphopenia, congenital cataracts, and skin changes [25].